标题
Drug repurposing for antimicrobial discovery
作者
关键词
-
出版物
Nature Microbiology
Volume 4, Issue 4, Pages 565-577
出版商
Springer Nature
发表日期
2019-03-05
DOI
10.1038/s41564-019-0357-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics
- (2018) Craig R. MacNair et al. Nature Communications
- Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience
- (2017) Hiram Villanueva-Lozano et al. INFECTION
- Screening a repurposing library for potentiators of antibiotics against Staphylococcus aureus biofilms
- (2017) Freija Van den Driessche et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors
- (2017) Andrea Astolfi et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Drug Repurposing Hub: a next-generation drug library and information resource
- (2017) Steven M Corsello et al. NATURE MEDICINE
- SuperDRUG2: a one stop resource for approved/marketed drugs
- (2017) Vishal B Siramshetty et al. NUCLEIC ACIDS RESEARCH
- On the Integration of In Silico Drug Design Methods for Drug Repurposing
- (2017) Eric March-Vila et al. Frontiers in Pharmacology
- A standard database for drug repositioning
- (2017) Adam S. Brown et al. Scientific Data
- Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance
- (2017) Jonathan M. Stokes et al. Nature Microbiology
- Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics
- (2017) J. Javier Hernandez et al. Frontiers in Oncology
- Zika Virus: Rapid Spread in the Western Hemisphere
- (2016) Lin H. Chen et al. ANNALS OF INTERNAL MEDICINE
- New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria
- (2016) Jourdan A. Andersson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
- (2016) Nicholas J. Barrows et al. Cell Host & Microbe
- Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth
- (2016) Hengli Tang et al. Cell Stem Cell
- Drug combination therapy increases successful drug repositioning
- (2016) Wei Sun et al. DRUG DISCOVERY TODAY
- Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study
- (2016) Joshua Rhein et al. LANCET INFECTIOUS DISEASES
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
- (2016) Yi-Yun Liu et al. LANCET INFECTIOUS DISEASES
- Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen
- (2016) Miao Xu et al. NATURE MEDICINE
- Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening
- (2016) Venkata Pothineni et al. Drug Design Development and Therapy
- Hospital transmittedCandida aurisinfections confirmed in the US
- (2016) Michael McCarthy BMJ-British Medical Journal
- Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction
- (2016) Edgar D. Coelho et al. PLoS Computational Biology
- A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases
- (2016) Ariel José Berenstein et al. PLoS Neglected Tropical Diseases
- Hospital transmittedCandida aurisinfections confirmed in the US
- (2016) Michael McCarthy BMJ-British Medical Journal
- Drug resistance in eukaryotic microorganisms
- (2016) Alan H. Fairlamb et al. Nature Microbiology
- Unconventional screening approaches for antibiotic discovery
- (2015) Maya A. Farha et al. Annals of the New York Academy of Sciences
- Computational and Practical Aspects of Drug Repositioning
- (2015) Tudor I. Oprea et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Structure–activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure
- (2015) Robert A. Mook et al. BIOORGANIC & MEDICINAL CHEMISTRY
- FDA's Expedited Approval Mechanisms for New Drug Products
- (2015) Erin E. Kepplinger BIOTECHNOLOGY LAW REPORT
- Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution
- (2015) Tobias Bollenbach CURRENT OPINION IN MICROBIOLOGY
- Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections
- (2015) Waleed Younis et al. CURRENT PHARMACEUTICAL DESIGN
- Drug repositioning and repurposing: terminology and definitions in literature
- (2015) Joris Langedijk et al. DRUG DISCOVERY TODAY
- Open innovation platforms to boost pharmaceutical collaborations: evaluating external compounds for desired biological activity
- (2015) Niclas Nilsson et al. Future Medicinal Chemistry
- Inhibitory effects of niclosamide on inflammation and migration of fibroblast-like synoviocytes from patients with rheumatoid arthritis
- (2015) Liuqin Liang et al. INFLAMMATION RESEARCH
- Systematic Drug Repositioning for a Wide Range of Diseases with Integrative Analyses of Phenotypic and Molecular Data
- (2015) Hiroaki Iwata et al. Journal of Chemical Information and Modeling
- Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa
- (2015) Miles W. Carroll et al. NATURE
- An analysis of the attrition of drug candidates from four major pharmaceutical companies
- (2015) Michael J. Waring et al. NATURE REVIEWS DRUG DISCOVERY
- The SIDER database of drugs and side effects
- (2015) Michael Kuhn et al. NUCLEIC ACIDS RESEARCH
- Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase
- (2015) Maya A. Farha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection
- (2015) Shanshan He et al. Science Translational Medicine
- A screen of approved drugs and molecular probes identifies therapeutics with anti–Ebola virus activity
- (2015) Lisa M. Johansen et al. Science Translational Medicine
- Auranofin: Repurposing an Old Drug for a Golden New Age
- (2015) Christine Roder et al. Drugs in research & development
- Incentives to Repurpose Existing Drugs for Orphan Indications
- (2015) Annette K. Kwok et al. ACS Medicinal Chemistry Letters
- New drug target in protozoan parasites: the role of thioredoxin reductase
- (2015) Rosa M. Andrade et al. Frontiers in Microbiology
- Evaluation of Ebola Virus Inhibitors for Drug Repurposing
- (2015) Peter B. Madrid et al. ACS Infectious Diseases
- Clinically Relevant Growth Conditions Alter Acinetobacter baumannii Antibiotic Susceptibility and Promote Identification of Novel Antibacterial Agents
- (2015) Jennifer M. Colquhoun et al. PLoS One
- Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
- (2014) Julie Dyall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Confronting the challenges of discovery of novel antibacterial agents
- (2014) Sheo B. Singh BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Update on the antibiotic resistance crisis
- (2014) Gian Maria Rossolini et al. CURRENT OPINION IN PHARMACOLOGY
- Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique
- (2014) Yanghuan Ye et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- 2013 FDA drug approvals
- (2014) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- A Case of Severe Ebola Virus Infection Complicated by Gram-Negative Septicemia
- (2014) Benno Kreuels et al. NEW ENGLAND JOURNAL OF MEDICINE
- Whole Animal Automated Platform for Drug Discovery against Multi-Drug Resistant Staphylococcus aureus
- (2014) Rajmohan Rajamuthiah et al. PLoS One
- Discovery and preclinical development of new antibiotics
- (2014) Diarmaid Hughes et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi
- (2014) Joseph D. Planer et al. PLoS Neglected Tropical Diseases
- Discovery of a small molecule that inhibits bacterial ribosome biogenesis
- (2014) Jonathan M Stokes et al. eLife
- Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
- (2014) Jennifer Kouznetsova et al. Emerging Microbes & Infections
- A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lamblia
- (2013) Noa Tejman-Yarden et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-Throughput Screening of a Collection of Known Pharmacologically Active Small Compounds for Identification of Candida albicans Biofilm Inhibitors
- (2013) Samuel A. Siles et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Drug Repurposing Screen Reveals FDA-Approved Inhibitors of Human HMG-CoA Reductase and Isoprenoid Synthesis That Block Cryptosporidium parvum Growth
- (2013) Kovi Bessoff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of Antivirulence Agents against Methicillin-Resistant Staphylococcus aureus
- (2013) Varandt Khodaverdian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and Anti-PlasmodiumActivity of Benzimidazole Analogues Structurally Related to Astemizole
- (2013) Gheorghe Roman et al. ChemMedChem
- Shifting from the single to the multitarget paradigm in drug discovery
- (2013) José L. Medina-Franco et al. DRUG DISCOVERY TODAY
- Phenotypic screens as a renewed approach for drug discovery
- (2013) Wei Zheng et al. DRUG DISCOVERY TODAY
- Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms
- (2013) N. Delattin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Drug repurposing: mining protozoan proteomes for targets of known bioactive compounds
- (2013) Adam Sateriale et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non-Small Cell Lung Cancer
- (2013) R. Li et al. MOLECULAR CANCER THERAPEUTICS
- More cuts loom for US science
- (2013) Lauren Morello NATURE
- A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
- (2013) Frédéric Ariey et al. NATURE
- Target identification and mechanism of action in chemical biology and drug discovery
- (2013) Monica Schenone et al. Nature Chemical Biology
- Opening the lead generation toolbox
- (2013) Peter B. Simpson et al. NATURE REVIEWS DRUG DISCOVERY
- Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis
- (2013) Afif Ben Salah et al. NEW ENGLAND JOURNAL OF MEDICINE
- PubChem BioAssay: 2014 update
- (2013) Yanli Wang et al. NUCLEIC ACIDS RESEARCH
- The ChEMBL bioactivity database: an update
- (2013) A. Patrícia Bento et al. NUCLEIC ACIDS RESEARCH
- Toward Repurposing Ciclopirox as an Antibiotic against Drug-Resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae
- (2013) Kimberly M. Carlson-Banning et al. PLoS One
- Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity
- (2013) F. Imperi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination approaches to combat multidrug-resistant bacteria
- (2013) Roberta J. Worthington et al. TRENDS IN BIOTECHNOLOGY
- Identification of the factors that result in obviousness rulings for biotech patents
- (2013) Fangyu Lin et al. Human Vaccines & Immunotherapeutics
- Drug repurposing a reality: from computers to the clinic
- (2013) Naiem T Issa et al. Expert Review of Clinical Pharmacology
- Inhibition of WTA Synthesis Blocks the Cooperative Action of PBPs and Sensitizes MRSA to β-Lactams
- (2012) Maya A. Farha et al. ACS Chemical Biology
- Adenylate Kinase Release as a High-Throughput-Screening-Compatible Reporter of Bacterial Lysis for Identification of Antibacterial Agents
- (2012) Anna C. Jacobs et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Life for an Old Drug: the Anthelmintic Drug Niclosamide Inhibits Pseudomonas aeruginosa Quorum Sensing
- (2012) F. Imperi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections
- (2012) Bing Zhai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Metabolic network analysis predicts efficacy of FDA-approved drugs targeting the causative agent of a neglected tropical disease
- (2012) Arvind K Chavali et al. BMC Systems Biology
- Repurposing Approved and Abandoned Drugs for the Treatment and Prevention of Cancer through Public-Private Partnership
- (2012) S. J. Weir et al. CANCER RESEARCH
- Phase I Study of the Antiangiogenic Antibody Bevacizumab and the mTOR/Hypoxia-Inducible Factor Inhibitor Temsirolimus Combined with Liposomal Doxorubicin: Tolerance and Biological Activity
- (2012) J. Moroney et al. CLINICAL CANCER RESEARCH
- Epidemiology of and Diagnostic Strategies for Toxoplasmosis
- (2012) F. Robert-Gangneux et al. CLINICAL MICROBIOLOGY REVIEWS
- A Repurposing Approach Identifies Off-Patent Drugs with Fungicidal Cryptococcal Activity, a Common Structural Chemotype, and Pharmacological Properties Relevant to the Treatment of Cryptococcosis
- (2012) Arielle Butts et al. EUKARYOTIC CELL
- Drug Screen Targeted at Plasmodium Liver Stages Identifies a Potent Multistage Antimalarial Drug
- (2012) Filipa P. da Cruz et al. JOURNAL OF INFECTIOUS DISEASES
- Ten Common Questions (and Their Answers) About Off-label Drug Use
- (2012) Christopher M. Wittich et al. MAYO CLINIC PROCEEDINGS
- A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target
- (2012) Anjan Debnath et al. NATURE MEDICINE
- Drug repurposing programmes get lift off
- (2012) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Fungal Infections Associated with Contaminated Methylprednisolone Injections
- (2012) Carol A. Kauffman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis
- (2012) P. P. SIMARRO et al. PARASITOLOGY
- Identifying mechanism-of-action targets for drugs and probes
- (2012) E. Gregori-Puigjane et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Liver-stage malaria parasites vulnerable to diverse chemical scaffolds
- (2012) E. R. Derbyshire et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing
- (2012) E. S. Snitkin et al. Science Translational Medicine
- Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects
- (2012) Andreas Jurgeit et al. PLoS Pathogens
- Amebiasis-Related Mortality among United States Residents, 1990–2007
- (2011) Janelle Gunther et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Doxycycline for Malaria Chemoprophylaxis and Treatment: Report from the CDC Expert Meeting on Malaria Chemoprophylaxis
- (2011) Kathrine R. Tan et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profiling
- (2011) To Ha Loi et al. BMC Medical Genomics
- A Phase I Trial of Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Patients with Advanced Gynecologic and Breast Malignancies
- (2011) J. W. Moroney et al. CLINICAL CANCER RESEARCH
- Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole
- (2011) M. Spitzer et al. Molecular Systems Biology
- Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
- (2011) Linda Ejim et al. Nature Chemical Biology
- TDR Targets: a chemogenomics resource for neglected diseases
- (2011) M. P. Magarinos et al. NUCLEIC ACIDS RESEARCH
- Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway
- (2011) Wenyan Lu et al. PLoS One
- The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
- (2011) R. Huang et al. Science Translational Medicine
- Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production
- (2011) F L Khanim et al. Blood Cancer Journal
- Discovery of Potent Small-Molecule Inhibitors of Multidrug-Resistant Plasmodium falciparum Using a Novel Miniaturized High-Throughput Luciferase-Based Assay
- (2010) E. Lucumi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Image-Based High-Throughput Drug Screening Targeting the Intracellular Stage of Trypanosoma cruzi, the Agent of Chagas' Disease
- (2010) J. C. Engel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-ThroughputGiardia lambliaViability Assay Using Bioluminescent ATP Content Measurements
- (2010) Catherine Z. Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pentamidine inhibits Coxiella burnetii growth and 23S rRNA intron splicing in vitro
- (2010) Michael F. Minnick et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Plasma protein binding may reduce antimicrobial activity by preventing intra-bacterial uptake of antibiotics, for example clindamycin
- (2010) A. Burian et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii
- (2010) S. Chopra et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect
- (2010) B. Zhai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- How to improve R&D productivity: the pharmaceutical industry's grand challenge
- (2010) Steven M. Paul et al. NATURE REVIEWS DRUG DISCOVERY
- PROMISCUOUS: a database for network-based drug-repositioning
- (2010) J. von Eichborn et al. NUCLEIC ACIDS RESEARCH
- Gene Expression Signature-Based Screening Identifies New Broadly Effective Influenza A Antivirals
- (2010) Laurence Josset et al. PLoS One
- A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
- (2010) Karuppiah Chockalingam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Optimal Drug Synergy in Antimicrobial Treatments
- (2010) Joseph Peter Torella et al. PLoS Computational Biology
- Antifungal Activity of Tamoxifen: In Vitro and In Vivo Activities and Mechanistic Characterization
- (2009) K. Dolan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Coordination Chemistry Based Approach to Lipophilic Inhibitors of 1-Deoxy-d-xylulose-5-phosphate Reductoisomerase
- (2009) Lisheng Deng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synergistic drug combinations tend to improve therapeutically relevant selectivity
- (2009) Joseph Lehár et al. NATURE BIOTECHNOLOGY
- Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection
- (2009) P. Gastaminza et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis
- (2009) Sarah L. Kinnings et al. PLoS Computational Biology
- Outer membrane permeability and antibiotic resistance
- (2008) Anne H. Delcour BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Revisiting the host as a growth medium
- (2008) Stacie A. Brown et al. NATURE REVIEWS MICROBIOLOGY
- Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation
- (2008) Tao Sun et al. NUCLEIC ACIDS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started